These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2190884

  • 1. Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF).
    Siena S, Bregni M, Ravagnani F, Brando B, Tarella C, Bonadonna G, Gianni AM.
    Haematologica; 1990; 75 Suppl 1():6-10. PubMed ID: 2190884
    [Abstract] [Full Text] [Related]

  • 2. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor.
    Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM.
    Blood; 1989 Nov 01; 74(6):1905-14. PubMed ID: 2478216
    [Abstract] [Full Text] [Related]

  • 3. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.
    Tong J, Hoffman R, Siena S, Srour EF, Bregni M, Gianni AM.
    Exp Hematol; 1994 Sep 01; 22(10):1016-24. PubMed ID: 8088376
    [Abstract] [Full Text] [Related]

  • 4. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S, Goldschmidt H, Ehrhardt R, Haas R.
    Exp Hematol; 1993 Apr 01; 21(4):508-14. PubMed ID: 7681782
    [Abstract] [Full Text] [Related]

  • 5. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct 01; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 6. Role of recombinant human granulocyte-macrophage colony stimulating factor for large scale collection of peripheral blood stem cells for autologous transplantation.
    Ravagnani F, Bregni M, Siena S, Sciorelli G, Gianni AM, Pellegris G.
    Haematologica; 1990 Oct 01; 75 Suppl 1():22-5. PubMed ID: 2190882
    [Abstract] [Full Text] [Related]

  • 7. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM.
    Exp Hematol; 1993 Nov 01; 21(12):1583-90. PubMed ID: 7691640
    [Abstract] [Full Text] [Related]

  • 8. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 9. Primitive hematopoietic progenitor cells are present in peripheral blood autografts.
    Tong J, Gianni AM, Siena S, Srour EF, Bregni M, Hoffman R.
    Blood Cells; 1994 Dec 01; 20(2-3):351-62; discussion 362-3. PubMed ID: 7538339
    [Abstract] [Full Text] [Related]

  • 10. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T, Muroi K, Tomizuka H, Amemiya Y, Miura Y.
    Stem Cells; 1995 May 01; 13(3):273-80. PubMed ID: 7542113
    [Abstract] [Full Text] [Related]

  • 11. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE, Bender J, Lee W, Schilling M, Smith A, Smith S, Unverzagt K, Law P, Burgess J.
    Blood Cells; 1994 May 01; 20(2-3):411-23. PubMed ID: 7538347
    [Abstract] [Full Text] [Related]

  • 12. Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
    Boiron JM, Marit G, Fabéres C, Cony-Makhoul P, Foures C, Ferrer AM, Cristol G, Sarrat A, Girault D, Reiffers J.
    Bone Marrow Transplant; 1993 Jul 01; 12(1):49-55. PubMed ID: 8104070
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec 01; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 14. Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma.
    Haas R, Ehrhardt R, Witt B, Goldschmidt H, Hohaus S, Pförsich M, Ehrlich H, Färber L, Hunstein W.
    Bone Marrow Transplant; 1993 Dec 01; 12(6):643-9. PubMed ID: 7511017
    [Abstract] [Full Text] [Related]

  • 15. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.
    Bender JG, Lum L, Unverzagt KL, Lee W, Van Epps D, George S, Coon J, Ghalie R, McLeod B, Kaizer H.
    Bone Marrow Transplant; 1994 Apr 01; 13(4):479-85. PubMed ID: 7517260
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
    Bone Marrow Transplant; 1998 Oct 01; 22(7):625-30. PubMed ID: 9818688
    [Abstract] [Full Text] [Related]

  • 17. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
    Vanásek J, Filip S, Medková V, Bláha M, Mericka P, Volenec K.
    Bone Marrow Transplant; 1998 Jan 01; 21(2):123-6. PubMed ID: 9489627
    [Abstract] [Full Text] [Related]

  • 18. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H, Mulder NH, Willemse PH, van der Graaf WT, Sleijfer DT, Zijlstra JG, Elias M, Sibinga CT, Vellenga E, de Vries EG.
    Anticancer Res; 1995 Jan 01; 15(6B):2851-6. PubMed ID: 8669878
    [Abstract] [Full Text] [Related]

  • 19. Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myeloma.
    Martínez E, Sureda A, Dalmases CD, Sánchez JA, Amill B, Tugues D, Sardá P, Miralles A, Brunet S, Domingo-Albós A, García J.
    Bone Marrow Transplant; 1996 Jul 01; 18(1):1-7. PubMed ID: 8831988
    [Abstract] [Full Text] [Related]

  • 20. Characterization of peripheral blood CD34+ progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor.
    Teofili L, Iovino MS, Sica S, Pierelli L, Menichella G, De Stefano V, Rumi C, Leone G.
    Exp Hematol; 1994 Sep 01; 22(10):990-5. PubMed ID: 7522187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.